Integrin inhibitor, RWJ 50271, Purity ≥98%

Synonym: 162112-37-0; RWJ50271; RWJ-50271; N-(3-Hydroxypropyl)-5-methyl-1-[4-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-4-carboxamide

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

RWJ 50271 is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin.

Molecular Weight

410.41

Molecular Formula

C₁₈H₁₇F₃N₄O₂S

Form

Lyophilized powder

Purity

≥98%

Titer

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects

Stability

In its lyophilized form, the chemical remains stable for 36 months.

Quality Level

Research grade

Applications

RWJ 50271 is a cytoskeletal signaling inhibitor that can be used for its effects on integrin-mediated cell adhesion, migration, and angiogenesis.

Storage

Store at -20ºC, and keep desiccated.